Assessment of the benefits derived from producing uncastrated boars that have received IMPROVAC® and been raised according to Canadian standards (Quebec)


Status:
Completed

 

Expertise:
Health and biosecurity | Meat Quality and Technical Services

Aim / objectives:
Assess the benefits of producing uncastrated boars that received Improvac® immunocastration vaccine and were raised according to Canadian standards (Quebec) by comparing the growth rate, feed conversion rate and carcass quality of the Improvac®-treated boars compared to surgically castrated boars.

Project Manager:
Christian Klopfenstein; Sheering Mathur, Pfizer Santé Animale